Marinus Pharma

FDA Has Ways to Go to Keep Pace with 2020/21 Approvals
BioSpace
Wed, 07/6/22 - 11:05 am
FDA
drug approvals
Amicus
Bluebird Bio
Bristol Myers Squibb
Eli Lilly
Marinus Pharma
Amylyx
Novartis
Marinus pushes on despite mid-stage doubts
EP Vantage
Wed, 08/18/21 - 10:53 am
Marinus Pharma
ganaxolone
epilepsy tuberous sclerosis complex
clinical trials
Marinus signs government contract worth up to $51M to advance drug candidate
Bizjournals
Mon, 09/14/20 - 11:49 pm
Marinus Pharma
government contract
BARDA
ganaxolone
The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings
Yahoo/Benzinga
Mon, 10/14/19 - 09:43 am
JNJ
Flexion Therapeutics
Novartis
Amgen
Clearside Biomedical
Alexion
Assertio Therapeutics
Aldeyra Therapeutics
Lineage Therapeutics
IMMUTEP
Marinus Pharma
Marinus leaves the way clear for Sage
EP Vantage
Wed, 07/24/19 - 10:31 am
Marinus Pharma
SAGE Therapeutics
ganaxolone
clinical trials
postpartum depression
The 3 Best Biotech Stocks of 2017
Motley Fool
Sun, 12/17/17 - 10:28 am
biotech
Sangamo
Xoma
Marinus Pharma
Why This Seizure Drug Matters So Much for Marinus Pharma
Yahoo/24-7 Wall St
Tue, 01/24/17 - 09:56 am
Marinus Pharma
CDKL5
seizures
ganaxolone
epilepsy
Marinus Pharmaceuticals gets a boost from the FDA
Bizjournals.com
Tue, 01/3/17 - 11:41 am
Marinus Pharma
FDA
Fragile X syndrome
ganaxolone
Marinus Pharma's trial of treatment for drug-resistant epilepsy failed to meet goals
Marketwatch
Mon, 06/13/16 - 10:32 am
Marinus Pharma
epilepsy
ganaxolone